Potential News for the second half of 2015

Last day of 2015 financial year. Not much sell-off. I guess yesterday was the major change-hand event.

Here's some of possible up-coming news for the second half.
1. Spin-off and eHealth. (we have been waiting for this for a while now)
2. Completion of offshoring process on Grael/Somte production (EEG already done)
3. Completion of redesign for product lines, based on halving cost of goods
4. More distribution agreement to be signed off in US and China.

For 2015 financial year, CMP is $33millons revenue, $3.5-4millions EBITDA and $1.8-2 NPAT.
Current price at 0.265 is trading at about 25x P/E. Fair valuation.

For small cap like CMP, growth is quite unpredictable. But, based on its initiatives to halve cost of goods, it is expected to save up to 7 millions. (Cost of Sale for 2014 is about $14millions)
Lower AUD/ growing revenue should generate additional profit.

2016 financial year will be the game changer where cost-reduction activities and new product line revenue starts to materialize. There's always risk,
but for CMP, the risk is not growing any profit.
But, the reward is creation of eHealth product division with market leading technology, fueled by plenty of cash funded by spin-off and cost saving initiatives.